Quantum-Si (NASDAQ:QSI - Get Free Report) will likely be releasing its Q4 2024 earnings data after the market closes on Monday, March 3rd. Analysts expect Quantum-Si to post earnings of ($0.18) per share and revenue of $1.23 million for the quarter. Investors that wish to register for the company's conference call can do so using this link.
Quantum-Si Stock Performance
Shares of NASDAQ QSI traded down $0.08 during mid-day trading on Monday, hitting $1.30. 8,717,051 shares of the stock were exchanged, compared to its average volume of 23,775,961. Quantum-Si has a twelve month low of $0.61 and a twelve month high of $5.77. The stock's fifty day simple moving average is $2.23 and its two-hundred day simple moving average is $1.44. The company has a market cap of $185.53 million, a P/E ratio of -2.03 and a beta of 2.69.
Insiders Place Their Bets
In other Quantum-Si news, Director Jonathan M. Rothberg sold 3,506,267 shares of the business's stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $3.34, for a total transaction of $11,710,931.78. Following the completion of the sale, the director now directly owns 1,250,000 shares of the company's stock, valued at approximately $4,175,000. The trade was a 73.72 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 30.04% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on QSI. Alliance Global Partners started coverage on Quantum-Si in a research report on Friday, February 7th. They issued a "buy" rating and a $3.75 price objective for the company. HC Wainwright reaffirmed a "buy" rating and issued a $5.50 price target on shares of Quantum-Si in a report on Tuesday, January 14th. Finally, Canaccord Genuity Group decreased their price objective on shares of Quantum-Si from $1.50 to $1.00 and set a "hold" rating on the stock in a report on Wednesday, November 13th.
Get Our Latest Analysis on Quantum-Si
Quantum-Si Company Profile
(
Get Free Report)
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Further Reading
Before you consider Quantum-Si, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.
While Quantum-Si currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
